M1A.29
Drug-induced chronic gout, multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Drug-induced chronic gout at multiple sites is a form of gout caused by the adverse effects of certain medications. This condition leads to persistent inflammation and joint damage due to the buildup of uric acid crystals, affecting various parts of the body. Recognizing and managing this type of gout is important to prevent long-term joint damage and improve quality of life.
Causes & Symptoms
Clinical Causes: Use of medications that increase uric acid levels, such as diuretics (water pills), aspirin, or immunosuppressants. Prolonged use or high doses of certain drugs leading to impaired uric acid excretion. Genetic predisposition affecting uric acid metabolism combined with drug effects. Underlying health conditions like kidney disease that worsen drug effects on uric acid levels.
Key Symptoms: Persistent joint pain, especially in multiple locations. Swelling and redness in affected joints. Tenderness and warmth around the joints. Formation of tophi, which are uric acid crystal deposits under the skin, often around joints or in soft tissues. Limited joint movement due to pain or joint damage.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history review, physical examination, blood tests measuring uric acid levels, and imaging studies like X-rays or ultrasound. Joint fluid analysis, where a sample is taken from a swollen joint, can help confirm the presence of uric acid crystals. The healthcare provider considers medication history to identify potential drug-induced causes.
Treatment Protocols: Managing drug-induced chronic gout at multiple sites includes several approaches:
Clinical Advice & FAQs
Billing Guidance
Is M1A.29 a billable ICD-10 code?
Yes, M1A.29 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M1A.29?
Clinical documentation must specify the nature of Drug-induced chronic gout, multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference